22007-72-3 Usage
Description
7-(α-L-Rhamnopyranosyloxy)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-4H-1-benzopyran-4-one, also known as quercetin O-glycoside, is a flavonoid compound found in various plants. It is characterized by the attachment of an α-L-rhamnopyranosyl moiety to the quercetin molecule at position 7 through a glycosidic linkage. 7-(α-L-Rhamnopyranosyloxy)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-4H-1-benzopyran-4-one exhibits antioxidant, anti-inflammatory, and anti-cancer properties, making it a potential candidate for pharmaceutical and nutraceutical applications.
Uses
Used in Pharmaceutical Applications:
7-(α-L-Rhamnopyranosyloxy)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-4H-1-benzopyran-4-one is used as a therapeutic agent for its antioxidant and anti-inflammatory properties. It helps in reducing oxidative stress and inflammation, which are common factors in various diseases, including cardiovascular and neurodegenerative disorders.
Used in Nutraceutical Applications:
In the nutraceutical industry, 7-(α-L-Rhamnopyranosyloxy)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-4H-1-benzopyran-4-one is used as a dietary supplement due to its health-promoting properties. It can be found in various products, such as dietary supplements, functional foods, and beverages, to enhance their antioxidant and anti-inflammatory benefits.
Used in Cosmetic Applications:
7-(α-L-Rhamnopyranosyloxy)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-4H-1-benzopyran-4-one is used as an active ingredient in the cosmetic industry for its antioxidant and anti-aging properties. It can be incorporated into skincare products, such as creams, lotions, and serums, to protect the skin from environmental stressors and promote a youthful appearance.
Used in Anticancer Applications:
7-(α-L-Rhamnopyranosyloxy)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-4H-1-benzopyran-4-one is used as an anticancer agent, particularly against various types of cancer. It has been shown to modulate several oncological signaling pathways, exerting inhibitory effects on tumor growth and progression. Additionally, it demonstrates synergistic anticancer effects when combined with conventional chemotherapeutic drugs, enhancing chemo-sensitivity and efficacy in resistant cases.
Used in Drug Delivery Systems:
To overcome the limitations of 7-(α-L-Rhamnopyranosyloxy)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-4H-1-benzopyran-4-one, novel drug delivery systems have been developed to enhance its applications and efficacy against cancer cells. Various organic and metallic nanoparticles have been employed as carriers for this compound's delivery, aiming to improve its delivery, bioavailability, and therapeutic outcomes.
Check Digit Verification of cas no
The CAS Registry Mumber 22007-72-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,0,0 and 7 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 22007-72:
(7*2)+(6*2)+(5*0)+(4*0)+(3*7)+(2*7)+(1*2)=63
63 % 10 = 3
So 22007-72-3 is a valid CAS Registry Number.
InChI:InChI=1/C21H20O11/c1-7-15(25)17(27)19(29)21(30-7)31-9-5-12(24)14-13(6-9)32-20(18(28)16(14)26)8-2-3-10(22)11(23)4-8/h2-7,15,17,19,21-25,27-29H,1H3/t7-,15-,17+,19+,21-/m0/s1
22007-72-3Relevant articles and documents
Expanded acceptor substrates flexibility study of flavonol 7-O-rhamnosyltransferase, AtUGT89C1 from Arabidopsis thaliana
Parajuli, Prakash,Pandey, Ramesh Prasad,Trang, Nguyen Thi Huyen,Oh, Tae Jin,Sohng, Jae Kyung
supporting information, p. 13 - 19 (2015/11/09)
Acceptor substrates flexibility of previously characterized flavonol 7-O-rhamnosyltransferase (AtUGT89C1) from Arabidopsis thaliana was explored with an endogenous nucleotide diphosphate sugar and five different classes of flavonoids (flavonols, flavones,
